|
1
|
25–27
|
Post
|
Leukemia
|
|
2
|
25–27
|
Post
|
Lymphoma
|
|
3
|
25–27
|
Post
|
Leukemia
|
|
4
|
25–27
|
Post
|
Lymphoma
|
|
5
|
25–27
|
Pre
|
Sarcoma
|
|
6
|
18–19
|
Pre
|
Lymphoma
|
|
7
|
> 27
|
Post
|
Sarcoma
|
|
8
|
22–24
|
Pre
|
Sarcoma
|
|
9
|
25–27
|
Post
|
Lymphoma
|
|
10
|
20–21
|
Pre
|
Sarcoma
|
|
11
|
22–24
|
Pre
|
Hematologic Condition Treated with Bone Marrow Transplant
|
|
12
|
25–27
|
Pre
|
Sarcoma
|
|
13
|
22–24
|
Pre
|
Sarcoma
|
|
14
|
> 27
|
Post
|
Leukemia
|
|
15
|
20–21
|
Pre
|
Central Nervous System Malignancy
|
|
16
|
22–24
|
Post
|
Central Nervous System Malignancy
|
|
17
|
20–21
|
Pre
|
Leukemia
|
|
18
|
25–27
|
Pre
|
Leukemia
|
|
19
|
22–24
|
Pre
|
Leukemia
|
|
20
|
18–19
|
Pre
|
Leukemia
|
|
21
|
20–21
|
Pre
|
Neuroblastoma
|
|
22
|
20–21
|
Pre
|
Central Nervous System Malignancy
|
|
23
|
18–19
|
Pre
|
Hematologic Condition Treated with Bone Marrow Transplant
|
|
24
|
20–21
|
Post
|
Lymphoma
|
|
25
|
22–24
|
Pre
|
Hematologic Condition Treated with Bone Marrow Transplant
|
|
26
|
25–27
|
Post
|
Sarcoma
|
|
27
|
> 27
|
Post
|
Lymphoma
|
|
28
|
25–27
|
Pre
|
Lymphoma
|
|
29
|
22–24
|
Pre
|
Sarcoma
|
